Use of Novoseven for arsenic trioxide-induced bleeding in PML

Am J Hematol. 2006 Sep;81(9):720. doi: 10.1002/ajh.20713.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Arsenic Trioxide
  • Arsenicals / administration & dosage
  • Arsenicals / adverse effects*
  • Arsenicals / therapeutic use
  • Factor VII / therapeutic use*
  • Factor VIIa
  • Hemorrhage / chemically induced
  • Hemorrhage / drug therapy*
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Lung Diseases / chemically induced
  • Lung Diseases / drug therapy*
  • Oxides / administration & dosage
  • Oxides / adverse effects*
  • Oxides / therapeutic use
  • Recombinant Proteins / therapeutic use

Substances

  • Antineoplastic Agents
  • Arsenicals
  • Oxides
  • Recombinant Proteins
  • Factor VII
  • recombinant FVIIa
  • Factor VIIa
  • Arsenic Trioxide